Perceptive Advisors
Fred Callori serves as a Board Member and Co-founder at Neurosterix since 2024. Currently, Fred holds the position of Managing Director at Perceptive Advisors and Senior Partner at Xontogeny, both since 2018 and 2017, respectively. In addition, Fred is a Board Member at Catabasis Pharmaceuticals, Inc., where involvement includes prior directorship at Quellis Biosciences until its acquisition in January 2021. Fred’s board memberships extend to CereVasc and Zucara Therapeutics Inc., both of which commenced in 2020. Prior to these roles, Fred was a Partner at Choate, Hall & Stewart from 1998 to 2017. Fred earned a Doctor of Law (JD) degree from Boston University School of Law from 1991 to 1994.
This person is not in any teams
Perceptive Advisors
Perceptive is focused on supporting the progress of the life sciences industry by identifying opportunities and directing financial resources to the most promising technologies in healthcare. The information presented in this page is included to enable professional networking by Perceptive Advisor’s employees and should not be used for any other purpose. As such, Perceptive Advisor’s use of LinkedIn is not an offer to, or solicitation of, any potential clients or investors for the provision of investment management, advisory or any other related services. No information posted by Perceptive Advisors should be construed as investment advice, or as an offer to sell, or a solicitation of an offer to buy, any security or other instrument.